Author: healthprofessionalradio

Dr. Jay Backstrom, MD, MPH, President and CEO, and Ted Myles, COO and CFO of Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company, discusses new TOPAZ 36-month apitegromab extension data reinforcing long-term substantial and sustained improvement of motor function in patients with nonambulatory spinal muscular atrophy (SMA).

Dr. Reid Merryman, MD, an attending physician in the Lymphoma Program at the Dana-Farber Cancer Institute discusses Genmab and AbbVie’s preliminary data from its ongoing phase 1/2 EPCORE™ NHL-2 trial investigating epcoritamab in patients across B-Cell lymphomas that were presented at the European Hematology Association’s (EHA) Annual Meeting 2023.   Read the abstract here.

Nationally known ophthalmologist, Dr. Neda Shamie, partner of the Maloney-Shamie Vision Institute in Los Angeles, discusses the signs, symptoms, and treatment options for cataracts, as well as the findings from Alcon’s global “Alcon Eye On Cataract Survey.” Please visit mycataracts.com for more information.

Minaa B., a licensed mental health professional discusses her new book “Owning Our Struggles” an important book advocating for mental health inclusivity. She talks about how community-care is as important as self-care, cultural healing practices, building healthy relationships, holding yourself accountable, and healing parent-child relationships.

Returning guest, Allison London Brown, CEO of LUMINELLE discusses LUMINELLE SUSTAINE endoscopic system and the recently FDA-cleared LUMINELLE Bx (Biopsy) RotoSheath of which she is a co-inventor. She talks about the uptick in the number of women diagnosed with uterine cancers due to the pandemic lockdown and certain procedures being considered elective. She shares her thoughts on the need for uterine screening in addition to mammograms and the disparity when it comes to women’s health.

Dr. Matthew Old, MD, Director of the Department of Otolaryngology–Head and Neck Surgery at The James, Ohio State University, Comprehensive Cancer Center discusses HPV-related cancer, cancer treatment/detection, and why vaccination is important for older adults.

Dr. Jeremy Abramson, Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center and principal investigator of the study discusses the updated efficacy and safety data results for Seagen’s ADCETRIS ® (brentuximab vedotin) in combination with an immunotherapy-containing regimen. These data were presented at the 17th International Conference on Malignant Lymphoma (ICML).

Rae Jimenez, Chief Product Officer at AAPC discusses medical coding and why it’s important for patients to know “what’s the code” prior to getting a surgery or procedure and how nurses and doctors can better advise their patients. Medical coding has also become a great career for many people allowing some to work from home.

KimberLee Heidmann, Executive Vice President of Patient Experience and Customer Success at Scout Clinical, part of the Meeting Protocol Worldwide family, discusses Scout Clinical’s mission to help patients stay enrolled in clinical trials. On average, clinical trial participants must travel over 60 miles one way to visit clinical trial sites, contributing to just over half of all trials being terminated due to insufficient patient enrollment and retention.

Returning guest, Sylvie Beljanski, Founder and Executive Vice President of the Beljanski Foundation and a renowned expert in the field of natural approaches to cancer, discusses the foundation’s latest research project on breast cancer stem cells. To learn more visit https://integrativecancerconference.com/